Literature DB >> 17321633

Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period.

Flavia Bortolotti1, Raffaele Iorio, Raffaele Jorio, Massimo Resti, Calogero Cammà, Matilde Marcellini, Raffaella Giacchino, Maria Grazia Marazzi, Gabriella Verucchi, Lucia Zancan, Cristiana Barbera, Giuseppe Maggiore, Pietro Vajro, Antonietta Giannattasio, Samuela Bartolacci.   

Abstract

BACKGROUND/AIMS: To evaluate the epidemiological profile of Italian children with hepatitis C virus (HCV) infection over a 15-year period.
METHODS: Fifteen tertiary care centers, belonging to a national Observatory established in 1998, retrospectively/prospectively recruited 806 consecutive HCV-infected, otherwise healthy, children seen from 1990 to 2004.
RESULTS: Seven hundred and sixty four were Italian and 42 from foreign countries. Newly-diagnosed cases declined from 332 in 1995-1999 to 196 in 2000-2004, while the proportion of foreign children rose from 3% to 13%. Transfusion-transmitted infection disappeared after 1992. Maternal infection (with drug abuse in 63% of cases in the North) has become the most important mode of HCV diffusion throughout Italy and the exclusive source for all children infected in 2000-2004. The prevalence of HCV genotypes 3 and 4 increased and that of genotype 1b decreased significantly (p<0.02). Male/female ratio was significantly (p<0.001) lower among vertically infected (0.6) than in transfused children (1.3).
CONCLUSIONS: The number of children with newly-diagnosed HCV infection is declining in Italy and most post-transfusion cases are now young adults. Thus foreign children could significantly contribute to the reservoir of pediatric infection in years to come. New infections result from maternal transmission and seem to privilege females and genotypes 3 and 4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321633     DOI: 10.1016/j.jhep.2006.12.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Viral hepatitis: Treating hepatitis C in children: an open horizon.

Authors:  Maria Guido; Flavia Bortolotti
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-05       Impact factor: 46.802

Review 2.  Viral infections during pregnancy.

Authors:  Michelle Silasi; Ingrid Cardenas; Ja-Young Kwon; Karen Racicot; Paula Aldo; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2015-01-13       Impact factor: 3.886

3.  Vertical transmission of hepatitis C virus: a tale of multiple outcomes.

Authors:  Alejandro Escobar-Gutiérrez; Hugo Soudeyns; Ariane Larouche; Juan Carlos Carpio-Pedroza; Armando Martinez-Guarneros; Carlos A Vazquez-Chacon; Salvador Fonseca-Coronado; Lilian H T Yamasaki; Karina Ruiz-Tovar; Mayra Cruz-Rivera
Journal:  Infect Genet Evol       Date:  2013-10-18       Impact factor: 3.342

4.  The impact of mode of acquisition on biological markers of paediatric hepatitis C virus infection.

Authors:  K England; C Thorne; H Harris; M Ramsay; M-L Newell
Journal:  J Viral Hepat       Date:  2011-06-22       Impact factor: 3.728

5.  APASL consensus statements and management algorithms for hepatitis C virus infection.

Authors:  Masao Omata; Tatsuo Kanda; Ming-Lung Yu; Osamu Yokosuka; Seng-Gee Lim; Wasim Jafri; Ryosuke Tateishi; Saeed S Hamid; Wan-Long Chuang; Anuchit Chutaputti; Lai Wei; Jose Sollano; Shiv Kumar Sarin; Jia-Horng Kao; Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2012-03-01       Impact factor: 9.029

6.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

7.  Treatment and follow up of children with chronic hepatitis C in Albania.

Authors:  Virtut Velmishi; Ermira Dervishi; Paskal Cullufi; Donjeta Bali; Vjollca Durro
Journal:  Virol J       Date:  2012-01-13       Impact factor: 4.099

Review 8.  Chronic hepatitis C virus infection in children and adolescents: Epidemiology, natural history, and assessment of the safety and efficacy of combination therapy.

Authors:  Giuseppe Indolfi; Elisa Bartolini; Davide Casavola; Massimo Resti
Journal:  Adolesc Health Med Ther       Date:  2010-10-05

9.  Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses.

Authors:  Jonathan R Honegger; Seungtaek Kim; Aryn A Price; Jennifer A Kohout; Kevin L McKnight; Mona R Prasad; Stanley M Lemon; Arash Grakoui; Christopher M Walker
Journal:  Nat Med       Date:  2013-10-27       Impact factor: 53.440

10.  IL-28B polymorphisms correlated with treatment response in HCV-4 mono-infected patients: a meta-analysis.

Authors:  Tonggang Liu; Kaihui Sha; Luhua Yang; Yun Wang; Liguo Zhang; Xianxian Liu; Fang Yang
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.